EMA starts review of GSK/Vir COVID-19 antibodyThe EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech’s COVID-19 antibody VIR-7831, which Share XEMA starts review of GSK/Vir COVID-19 antibodyhttps://pharmaphorum.com/news/ema-starts-review-of-gsk-vir-covid-19-antibody/
Activist investor Elliott builds stake in GSK after fresh trial upsetActivist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial Share XActivist investor Elliott builds stake in GSK after fresh trial upsethttps://pharmaphorum.com/news/activist-investor-elliott-builds-stake-in-gsk-after-fresh-trial-upset/
AZ aims at Pfizer, GSK with potential new PARP cancer drugAstraZeneca’s Lynparza (olaparib) blazed a trail for the new class of PARP drugs when it was approved in Share XAZ aims at Pfizer, GSK with potential new PARP cancer drughttps://pharmaphorum.com/news/az-aims-at-pfizer-gsk-with-potential-new-parp-cancer-drug/
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trialAntios has raised $96 million in Series B financing to support the ongoing phase 2 development of its Share XRace for hepatitis B drug intensifies as Antios raises $96m for phase 2 trialhttps://pharmaphorum.com/news/race-for-hepatitis-b-drug-intensifies-as-antios-raises-96m-for-phase-2-trial/
GSK on COVID and vaccine development: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery Share XGSK on COVID and vaccine development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-covid-vaccines
World leaders call for international pandemic preparedness treatyMore than 20 world leaders have called for an international treaty for pandemic preparedness to protect the world Share XWorld leaders call for international pandemic preparedness treatyhttps://pharmaphorum.com/news/world-leaders-call-for-international-pandemic-preparedness-treaty/
Lilly and GSK/Vir antibody pairing offers resistant COVID-19 hopeTwo antibodies targeting different parts of the COVID-19 virus spike protein, from Eli Lilly and GlaxoSmithKline/Vir Biotech, can Share XLilly and GSK/Vir antibody pairing offers resistant COVID-19 hopehttps://pharmaphorum.com/news/lilly-and-gsk-vir-antibody-pairing-offers-resistant-covid-19-hope/
GSK fires former R&D chief Slaoui after sexual harassment allegationGlaxoSmithKline has fired its former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it Share XGSK fires former R&D chief Slaoui after sexual harassment allegationhttps://pharmaphorum.com/news/gsk-fires-former-rd-chief-slaoui-after-sexual-harassment-allegation/
GSK and Medicago’s plant-based COVID shot heads into phase 3At the start of the pandemic GlaxoSmithKline made its vaccine booster tech available looking for collaborations with other Share XGSK and Medicago’s plant-based COVID shot heads into phase 3https://pharmaphorum.com/news/gsk-and-medicagos-plant-based-covid-shot-heads-into-phase-3/
